Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (3): 482-484    DOI: 10.12891/ceog4667.2019
Case Report Previous articles | Next articles
Simultaneous cornual heterotopic and intrauterine pregnancy following in vitro fertilization/embryo transfer: new conservative surgery with laparoscopic lesion resection
B. Luo1, 2, L. Luo1, 3, *()
1Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China
2Department of Obstetrics and Gynecology, Women and Children Center Hospital of Chengdu, Chengdu, China
3Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China
Download:  PDF(401KB)  ( 195 ) Full text   ( 2 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Objective: To report a case of simultaneous heterotopic cornual and intrauterine pregnancy managed with laparosopic lesion resection. Results: A 37-year-old woman with heterotopic cornual and intrauterine pregnancy after assisted reproductive technologies (ART) was treated with laparosopic lesion resection. Finally the integrity of uterus was maintained and the patient delivered at term by cesarean section. Conclusion: This is the first report on managing heterotopic cornual and intrauterine pregnancy by lesion resection with laparoscopy. This minimally new conservative surgery can be consider in the management of heterotopic cornual pregnancy.

Key words:  Cornual heterotopic pregnancy      IVF      New conservative surgery     
Published:  10 June 2019     
*Corresponding Author(s):  L. LUO     E-mail:  feigagasmile@163.com

Cite this article: 

B. Luo, L. Luo. Simultaneous cornual heterotopic and intrauterine pregnancy following in vitro fertilization/embryo transfer: new conservative surgery with laparoscopic lesion resection. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 482-484.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4667.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I3/482

[1] Z. Merhi, J. Zhang. At-Home IVF Kit: application during the COVID-19 pandemic[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 653-659.
[2] C. Chan, J.W. Wang, C.W. Wang, C.W. Chang. A pitfall in ultrasonographic diagnosis–heterotopic cornual pregnancy initially misdiagnosed as leiomyoma[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 296-298.
[3] M.S. Jo, H.J. Lee, Y.J. Lee, S.C. Kim, J.K. Joo, K.S. Lee. Which is the safer method for trophectoderm biopsy in mouse blastocyst, mechanical or laser?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 27-30.
[4] P. Bakas, M. Simopoulou, P. Panagopoulos, N. Salakos, Ch. Siristatidis. Luteal phase progesterone and estradiol concentrations and their relation to the outcome of IVF/ICSI cycles with controlled ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 727-730.
[5] J.-K. Joo, J.-E. Jeong, H.-G. Kim, S.-C. Kim, C.-W. Kim, K.-S. Lee. Effect of laser-assisted three area zona thinning at the 8-cell embryo on the hatching of mouse blastocysts[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 231-234.
[6] Chunjuan Shen, Liping Wang, Xiaojie Wu, Shuhui Mao, Chunxia Fang. The relationship between vitamin D and IVF: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 12-15.
[7] M.B. Celtemen, P. Telli Celtemen, N. Bozkurt, C. Karakaya, S. Elberg, R.H. Gursoy. Follicular fluid anti-Müllerian hormone, inhibin-A, progesterone, and estradiol level differences in patients under controlled ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 166-169.
[8] Bo Ma, Yuhu Li, Xiulan Zhang, Liuguang Zhang, Ning Li, Ping Yu. Supplementation of IVF solutions with melatonin improves assisted reproductive technology results[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 209-213.
[9] P. Bakas, M. Creatsa, P. Panagopoulos, N. Vlahos, E. Papadakis, M. Simopoulou. Outcome and recurrence risk of premature progesterone rise in IVF/ICSI cycles using GnRH antagonists for pituitary down-regulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 44-47.
[10] A.J. Jakimiuk, M.A. Nowicka, M. Zagozda, K. Koziol, P. Lewandowski, T. Issat. Levels of EG-VEGF and VEGF in serum and in the follicular fluid on the day of oocyte retrieval and reproductive outcome among IVF patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 93-97.
[11] P. Telli Celtemen, N. Bozkurt, M. Erdem, M.B. Celtemen, A. Erdem, M. Öktem, R.O. Karabacak. What is the best initial cycle IVF protocol for patients over 35 years old?[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 721-725.
[12] B. Bechev, M. Konovalova. A very rare case of ectopic intramural pregnancy after IVF-ET[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 802-803.
[13] P. Bakas, I. Boutas, M. Giner, P. Panagopoulos, L. Aravantinos. GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 279-282.
[14] H. Akın, S. Kumbasar, B.A. Şık, S. Salman, M. Temur, F. Çakıroğlu, R. Özyurt, M. Küçükbaş. Comparison of GnRH antagonist and agonist mini-dose long protocols in infertile cases undergoing controlled ovarian hyperstimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 116-121.
No Suggested Reading articles found!